<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have analysed the incidence and risk factors for the occurrence of invasive <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infections</z:e> (IFI) among 395 recipients of an allogeneic peripheral blood stem cell transplantation (PBSCT) from a human leucocyte antigen (HLA)-identical sibling </plain></SENT>
<SENT sid="1" pm="."><plain>IFI (n = 50) occurred in 46 patients, giving an overall probability of 14% </plain></SENT>
<SENT sid="2" pm="."><plain>There were 12 cases of <z:e sem="disease" ids="C1609535" disease_type="Disease or Syndrome" abbrv="">invasive candidiasis</z:e> (3%), with only one <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Non-Candida IFI occurred in 37 patients (12% probability), mostly invasive <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> (n = 32) </plain></SENT>
<SENT sid="4" pm="."><plain>In multivariate analysis the only two significant variables associated with a higher risk of developing a non-Candida IFI were the development of moderate-to-severe <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> (GvHD, P &lt; 0.0001; OR 4.6) and having received steroid prophylaxis for GvHD (P = 0.04; OR 2.1) </plain></SENT>
<SENT sid="5" pm="."><plain>In multivariate analysis the variables associated with a lower overall survival after PBSCT were development of a non-Candida IFI (P &lt; 0.0001; OR 5.6), non-early disease phase (P = 0.0001; OR 1.9), steroid prophylaxis (P = 0.02; OR 1.4), moderate-to-severe GvHD (P = 0.01; OR 1.6) and <z:e sem="disease" ids="C0010823" disease_type="Disease or Syndrome" abbrv="">cytomegalovirus infection</z:e> post transplant (P = 0.001; OR 1.8) </plain></SENT>
<SENT sid="6" pm="."><plain>Our results show that non-Candida IFI (in particular <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e>) was an important cause of infectious morbidity and mortality after an HLA-identical sibling PBSCT, while <z:e sem="disease" ids="C1609535" disease_type="Disease or Syndrome" abbrv="">invasive candidiasis</z:e> was rare </plain></SENT>
<SENT sid="7" pm="."><plain>Use of steroid prophylaxis and, in particular, the development of moderate-to-severe GvHD post transplant were risk factors for non-Candida IFI </plain></SENT>
<SENT sid="8" pm="."><plain>Prophylactic strategies for these <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> should thus take into account these risk factors </plain></SENT>
</text></document>